Skip Navigation

European Journal of Heart Failure 2007 9(4):370-376; doi:10.1016/j.ejheart.2006.09.010
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Radauceanu, A.
Right arrow Articles by Zannad, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radauceanu, A.
Right arrow Articles by Zannad, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society of Cardiology

Residual stress ischaemia is associated with blood markers of myocardial structural remodelling

Anca Radauceanua,b, Frédéric Moulinb,c, Wassila Djaballahd, Pierre Y. Marieb,d, François Allaf, Brigitte Doussete, Jean M. Viriona,f, Josette Capiaumonta,b, Gilles Karcherd, Etienne Aliotc and Façez Zannada,b,c,*

a Centre Investigation Clinique (CIC) CHU-INSERM Nancy, France
b Unité mixte UHP-INSERM U684 "Rigidité, Fibrose et Risque Cardio-Vasculaire", CHU Nancy, France
c Département des Maladies Cardiovasculaires CHU Nancy, France
d Service de Médecine Nucléaire CHU Nancy, France
e Laboratoire Central de Chimie CHU Nancy, France
f Service d'Epidémiologie et Evaluation Clinique CHU Nancy, France

* Corresponding author. Centre d'Investigation Clinique (CIC) CHU-INSERM, Hôpital Jeanne d'Arc, BP 303, 54201 Dommartin-lès-Toul, France. Tel.: +33 3 83 65 66 25; fax: +33 3 83 65 66 19. E-mail address: f.zannad{at}chu-nancy.fr


   Abstract

Background: Long-term prognosis of coronary artery disease (CAD) patients is worsened when stress ischemia persists on treatment, but the relationship with adverse cardiac remodelling had never been investigated.

Aim: To analyze changes in blood markers of fibrosis in patients with chronic CAD exhibiting exercise ischaemia.

Methods: Circulating markers of collagen: (i) turnover (amino-terminal propeptide of collagen-III [PIIINP]) and (ii) degradation (matrix metalloproteinase 1 [MMP-1]), were obtained in 139 CAD patients referred for exercise 201Tl-SPECT.

Results: In the 57 patients who had SPECT-ischaemia, PIIINP was higher (4.3±2.9 µg L–1 vs. 3.1±1.5 µg L–1, p=0.002) and MMP-1 lower (3.8±2.1 µg L–1 vs. 4.7±2.8 µg L–1, p=0.04) than in the 82 patients without SPECT-ischaemia. PIIINP was independently related to LV volume, SPECT-ischaemia and age, whereas MMP-1 was related to current treatment with ACEI and β-blockers (p<0.05).

In the 104 patients with a normal LV ejection fraction, only PIIINP was related to SPECT-ischaemia (4.1±2.2 µg L–1 vs. 3.1±1.5 µg L–1, p=0.01).

Conclusion: In patients with chronic CAD, exercise ischaemia is associated with increased collagen-III turnover, independently of concomitant medications and even when LV ejection fraction is normal. Long-term, this increase might relate to adverse cardiac remodelling even when cardiac function is not clearly affected at baseline.

Key Words: Coronary artery disease • Exercise ischaemia • SPECT • Remodelling • Collagen • Fibrosis

Received November 23, 2005; Revised June 8, 2006; Accepted September 25, 2006


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
W. Iraqi, P. Rossignol, M. Angioi, R. Fay, J. Nuee, J. M. Ketelslegers, J. Vincent, B. Pitt, and F. Zannad
Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study
Circulation, May 12, 2009; 119(18): 2471 - 2479.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.